Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis
- Conditions
- Actinic Keratosis
- Interventions
- Other: Amulez and sunlightOther: Amulez and red light treatment
- Registration Number
- NCT03805737
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.
- Detailed Description
Subjects who enroll into this research study, their participation in this study will last up to 6 months. They will be asked to return to the clinic 3-4 times.
Subjects will be randomized into one of two study arms:
Arm 1 - Indoor Daylight PDT Therapy Arm 2 - FDA Approved Standard Light Therapy Treatment
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
- All patients with actinic keratosis appearing at the Dermatology Clinic for PDT treatment.
- Age ≥ 18 years older.
- Pregnant women or women who are breast-feeding.
- Any patients with a condition that makes them not suitable for clinical PDT.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Indoor Daylight PDT Therapy Amulez and sunlight Ameluz will be applied to skin. This will be followed by a 30-minute incubation period. Subsequently, you will be exposed to natural sunlight through a window for 2 hours. Post-treatment assessments will be performed and you will be given instruction on appropriate sun protection methods. FDA Approved Standard Light Therapy Treatment Amulez and red light treatment Ameluz will be applied to skin. This will be followed by a 30-minute incubation period. Subsequently, you will receive Red Light Treatment for 10 minutes. Post-treatment assessments will be performed and you will be given instruction on appropriate sun protection methods.
- Primary Outcome Measures
Name Time Method Change in the amount of PpIX in the lesion Baseline and immediately post procedure Secondary diagnostic study to determine if low-cost cellphone-based skin dosimetry in PDT can facilitate objective measurement of drug levels.
Changes or clearing of the lesions Baseline, immediately post-procedure (2 hours) and one and 6 months The primary aim of this study is to study if indoor daylight PDT can be as effective as regular lamp light PDT. This study can be confounded by the amount of PpIX produced in the lesions as well as the clearing of lesions at one month and six months.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dartmouth Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States